Methylenedioxymethamphetamine
From Ganfyd
(Redirected from MDMA)
rINN: Methylenedioxymethamphetamine
Other Names
MDMA, methylenedioxymethamfetamine, Ecstasy, 3,4-methylenedioxymethamphetamine, N-methyl-3,4-methylenedioxyamphetamine, 1-(1,3- benzodioxol-5-yl)-N- methylpropan-2- amine
Pharmacological Information
Web information on Methylenedioxymethamphetamine
Relevant Clinical Literature
UK Guidance
Regulatory Literature
Other Literature
Please read pharmacological data limitations
Other Wikis
Medpedia on Methylenedioxymethamphetamine (Less technical, good quality control)
Wikipedia on Methylenedioxymethamphetamine (Less technical, ? quality control)
Common drug of abuse as hallucinogen. Causes long-lasting changes in brain serotonergic systems that may be clinically significant[1][2]. A cause of serotonin syndrome and idiosyncratic severe reactions including disseminated intravascular coagulation and hepatitis[3].
References
- ↑ Murphy PN, Bruno R, Ryland I, Wareing M, Fisk JE, Montgomery C, Hilton J. The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses. Human psychopharmacology. 2012 Mar; 27(2):113-38.(Link to article – subscription may be required.)
- ↑ Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Archives of general psychiatry. 2012 Apr; 69(4):399-409.(Link to article – subscription may be required.)
- ↑ Nadkarni GN, Hoskote SS, Piotrkowski J, Annapureddy N. Serotonin Syndrome, Disseminated Intravascular Coagulation, and Hepatitis After a Single Ingestion of MDMA in an Asian Woman. American journal of therapeutics. 2012 Jun 16.(Epub ahead of print) (Link to article – subscription may be required.)
